Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of Infection and Public Health|May 11, 2017
Epidemiology and outcome of invasive fungal infections and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi ArabiaRima Moghnieh, Adel F Alothman, Abdulhakeem O Althaqafi, et al.Journal of Medicinal Chemistry|September 15, 1995
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationshipsR C Schnur, M L Corman, R J Gallaschun, et al.Journal of Medicinal Chemistry|September 15, 1995
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivativesR C Schnur, M L Corman, R J Gallaschun, et al.Journal of Medicinal Chemistry|May 23, 1997
Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonistY L Chen, R S Mansbach, S M Winter, et al.Drugs in Context|April 25, 2022
Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndromeSteven H Abman, Nicholas R Fox, M Ibrahim Malik, et al.Future Oncology (London, England)|August 3, 2021
Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in SpainJosé-Ángel Hernández-Rivas, Mario Arnao, José Maria Arguiñano Pérez, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 18, 2006
Consensus conference on the stapled transanal rectal resection (STARR) for disordered defaecationM L Corman, A Carriero, T Hager, et al.Journal of Medicinal Chemistry|February 22, 2008
2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonistsYuhpyng L Chen, R Scott Obach, John Braselton, et al.The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophreniaC J Schmidt, D S Chapin, J Cianfrogna, et al.Diseases of the Colon and Rectum|September 28, 2002
The safety and efficacy of the artificial bowel sphincter for fecal incontinence: results from a multicenter cohort studyW Douglas Wong, Susan M Congliosi, Michael P Spencer, et al.Pageof 9